Inactive Instrument
ASLAN Pharmaceuticals Limited Stock
Stocks
ASLN
US04522R3093
Biotechnology & Medical Research
| 1 day | -14.27% |
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Firth
CEO | Chief Executive Officer | 53 | 01/01/2011 |
Kiran Asarpota
DFI | Director of Finance/CFO | 47 | 01/11/2010 |
| Chief Tech/Sci/R&D Officer | - | 15/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Carl Firth
CHM | Chairman | 53 | 01/06/2014 |
Andrew Howden
CHM | Chairman | 66 | 26/07/2019 |
Neil Graham
BRD | Director/Board Member | 67 | 18/02/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -14.27% | -76.47% | - | - | 1.7M | ||
| -1.34% | -3.09% | +56.10% | +68.83% | 65.45B | ||
| -0.12% | -3.16% | +7.67% | +90.50% | 58.93B | ||
| +0.71% | +0.78% | +26.74% | +87.91% | 55.21B | ||
| -2.34% | -3.90% | +10.90% | +115.97% | 46.1B | ||
| +0.09% | -6.08% | +18.67% | +25.90% | 42.49B | ||
| -2.58% | +0.24% | +18.54% | +41.28% | 35.56B | ||
| -1.76% | -11.56% | +126.44% | +649.27% | 34.57B | ||
| +0.89% | -0.48% | +77.51% | +58.24% | 32.46B | ||
| -1.69% | -0.79% | -40.58% | +382.68% | 26.28B | ||
| Average | -2.24% | -3.40% | +33.55% | +168.95% | 44B | |
| Weighted average by Cap. | -0.82% | -3.29% | +33.69% | +143.55% |
Employees
35
















